iPS derived cardiomyocytes as a tool to test the clinical significance and drug effectiveness in a novel mutation linked to CPVT
| Institution | Charité - Universitätsmedizin Berlin |
|---|---|
| Project leader | Felix Hohendanner |
| Site | Berlin |
| Project type | Shared Expertise (SE) |
| Funding | € 29.821,00 |
| SE Trait | SE-Partner |
| SE Number | SE029 |
| Begin | 01.07.2021 |
| End | 30.07.2023 |
| Partnerprojekte |
Förderkennzeichen
81X2100268
Projektnummer
1374